Ep. 440 Ultrasound’s Role in Endoleak Monitoring with Dr. David Guez

BackTable Vascular & Interventional

In this episode, Dr. David Guez discusses the advancements in contrast enhanced ultrasound, its application in detecting endoleaks, and his journey of learning and applying this modality from residency to his current practice.

Dr. Guez emphasizes ultrasound’s utility in lesion characterization, endoleak monitoring, and sparing patients from more invasive diagnostic procedures. The doctors delve into the specifics of using ultrasound contrast agents, particularly LUMASON and its intravascular utility for real-time monitoring of disease states with superior resolution compared to CT or MRI. Dr. Guez also discusses the potential for contrast enhanced ultrasound in interventional radiology, including diagnosing vascular lesions and augmenting tumor treatments. The conversation highlights the technique’s advantages, its high sensitivity for endoleaks, and potential areas for future research and application. The episode underscores the underutilized potential of contrast enhanced ultrasound in both diagnostic and interventional radiology settings.

---

CHECK OUT OUR SPONSOR

Reflow Medical

https://www.reflowmedical.com/

---

SHOW NOTES

00:00 - Introduction

03:54 - Exploring the Basics of Contrast Enhanced Ultrasound

06:49 - Clinical Applications and Advantages of Contrast Enhanced Ultrasound

09:15 - Contrast Enhanced Ultrasound in Action: Diagnosing Endoleaks

23:52 - Future of Contrast Enhanced Ultrasound in Interventional Radiology

27:02 - Closing Thoughts

---

RESOURCES

Bracco LUMASON:

https://lumason.com/

Nontraditional Uses of US Contrast Agents in Abdominal Imaging and Intervention:

https://pubs.rsna.org/doi/full/10.1148/rg.220016

Book written by Andrej Lyshchik, MD, PhD (Thomas Jefferson) - Specialty Imaging: Fundamentals of CEUS:

https://www.amazon.com/Specialty-Imaging-Fundamentals-Andrej-Lyshchik/dp/0323625649

Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity:

https://pubmed.ncbi.nlm.nih.gov/32890324/

Contrast-enhanced ultrasound (CEUS) versus computed tomography angiography (CTA) in detection of endoleaks in post-EVAR patients. Are delayed type II endoleaks being missed? A systematic review and meta-analysis:

https://pubmed.ncbi.nlm.nih.gov/26191109/